• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗结核噻吩类化合物定义了 Pks13 在分枝菌酸生物合成中的需求。

Antituberculosis thiophenes define a requirement for Pks13 in mycolic acid biosynthesis.

机构信息

Division of Infectious Disease, New Jersey Medical School, University of Medicine and Dentistry of New Jersey, Newark, New Jersey, USA.

出版信息

Nat Chem Biol. 2013 Aug;9(8):499-506. doi: 10.1038/nchembio.1277. Epub 2013 Jun 16.

DOI:10.1038/nchembio.1277
PMID:23770708
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3720791/
Abstract

We report a new class of thiophene (TP) compounds that kill Mycobacterium tuberculosis by the previously uncharacterized mechanism of Pks13 inhibition. An F79S mutation near the catalytic Ser55 site in Pks13 conferred TP resistance in M. tuberculosis. Overexpression of wild-type Pks13 resulted in TP resistance, and overexpression of the Pks13(F79S) mutant conferred high resistance. In vitro, TP inhibited fatty acyl-AMP loading onto Pks13. TP inhibited mycolic acid biosynthesis in wild-type M. tuberculosis, but it did so to a much lesser extent in TP-resistant M. tuberculosis. TP treatment was bactericidal and equivalent to treatment with the first-line drug isoniazid, but it was less likely to permit emergent resistance. Combined isoniazid and TP treatment resulted in sterilizing activity. Computational docking identified a possible TP-binding groove within the Pks13 acyl carrier protein domain. This study confirms that M. tuberculosis Pks13 is required for mycolic acid biosynthesis, validates it as a druggable target and demonstrates the therapeutic potential of simultaneously inhibiting multiple targets in the same biosynthetic pathway.

摘要

我们报告了一类新的噻吩(TP)化合物,它们通过以前未被描述的 Pks13 抑制机制杀死结核分枝杆菌。Pks13 催化 Ser55 位点附近的 F79S 突变赋予结核分枝杆菌对 TP 的抗性。野生型 Pks13 的过表达导致 TP 抗性,而 Pks13(F79S)突变体的过表达赋予高抗性。在体外,TP 抑制了 Pks13 上的酰基辅酶 A-AMP 的加载。TP 抑制了野生型结核分枝杆菌中的分枝菌酸生物合成,但在 TP 抗性结核分枝杆菌中抑制程度要小得多。TP 处理具有杀菌作用,与一线药物异烟肼相当,但不太可能产生耐药性。异烟肼和 TP 联合治疗具有杀菌活性。计算对接确定了 Pks13 酰基辅酶 A 蛋白结构域内可能的 TP 结合槽。本研究证实了结核分枝杆菌 Pks13 是分枝菌酸生物合成所必需的,验证了它作为一个可成药的靶点,并证明了同时抑制同一生物合成途径中的多个靶标在治疗上的潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/28b4/3720791/11c14f620d94/nihms481027f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/28b4/3720791/d285e2fe09e9/nihms481027f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/28b4/3720791/5feecb0fd800/nihms481027f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/28b4/3720791/11c14f620d94/nihms481027f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/28b4/3720791/d285e2fe09e9/nihms481027f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/28b4/3720791/5feecb0fd800/nihms481027f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/28b4/3720791/11c14f620d94/nihms481027f3.jpg

相似文献

1
Antituberculosis thiophenes define a requirement for Pks13 in mycolic acid biosynthesis.抗结核噻吩类化合物定义了 Pks13 在分枝菌酸生物合成中的需求。
Nat Chem Biol. 2013 Aug;9(8):499-506. doi: 10.1038/nchembio.1277. Epub 2013 Jun 16.
2
Identification of inhibitors targeting polyketide synthase 13 of Mycobacterium tuberculosis as antituberculosis drug leads.鉴定靶向结核分枝杆菌聚酮合酶 13 的抑制剂作为抗结核药物先导物。
Bioorg Chem. 2021 Sep;114:105110. doi: 10.1016/j.bioorg.2021.105110. Epub 2021 Jun 21.
3
Polyketide Synthase 13 (Pks13) Inhibition: A Potential Target for New Class of Anti-tubercular Agents.聚酮合酶 13(Pks13)抑制:新型抗结核药物的潜在靶点。
Curr Top Med Chem. 2024;24(27):2362-2376. doi: 10.2174/0115680266322983240906055750.
4
Synthesis and evaluation of new 2-aminothiophenes against Mycobacterium tuberculosis.新型2-氨基噻吩对结核分枝杆菌的合成及评估
Org Biomol Chem. 2016 Jul 7;14(25):6119-6133. doi: 10.1039/c6ob00821f. Epub 2016 Jun 2.
5
The Pks13/FadD32 crosstalk for the biosynthesis of mycolic acids in Mycobacterium tuberculosis.结核分枝杆菌中参与分枝菌酸生物合成的Pks13/FadD32相互作用
J Biol Chem. 2009 Jul 17;284(29):19255-64. doi: 10.1074/jbc.M109.006940. Epub 2009 May 12.
6
Antibacterial drugs: hitting the tuberculosis wall.抗菌药物:攻克结核病难题
Nat Rev Drug Discov. 2013 Aug;12(8):578-9. doi: 10.1038/nrd4080.
7
Solution structure of the type I polyketide synthase Pks13 from Mycobacterium tuberculosis.结核分枝杆菌 I 型聚酮合酶 Pks13 的结构解析。
BMC Biol. 2022 Jun 21;20(1):147. doi: 10.1186/s12915-022-01337-9.
8
Structure-Based Development of 3,4-Fused Tricyclic Benzofuran Derivatives as Polyketide Synthase 13 Inhibitors with Negligible hERG Inhibition.基于结构开发3,4-稠合三环苯并呋喃衍生物作为对人醚-去极化钾通道抑制作用可忽略不计的聚酮合酶13抑制剂。
J Med Chem. 2025 Mar 27;68(6):6312-6327. doi: 10.1021/acs.jmedchem.4c02635. Epub 2025 Mar 6.
9
Structure-based development of N-Arylindole derivatives as Pks13 inhibitors against Mycobacterium tuberculosis.基于结构开发N-芳基吲哚衍生物作为抗结核分枝杆菌的Pks13抑制剂。
Eur J Med Chem. 2025 Feb 5;283:117148. doi: 10.1016/j.ejmech.2024.117148. Epub 2024 Dec 15.
10
Design and synthesis of mycobacterial pks13 inhibitors: Conformationally rigid tetracyclic molecules.设计和合成分枝杆菌 pks13 抑制剂:构象刚性四环分子。
Eur J Med Chem. 2021 Mar 5;213:113202. doi: 10.1016/j.ejmech.2021.113202. Epub 2021 Jan 21.

引用本文的文献

1
SuFEx-based antitubercular compound irreversibly inhibits Pks13.基于SuFEx的抗结核化合物可不可逆地抑制Pks13。
Nature. 2025 Jul 30. doi: 10.1038/s41586-025-09286-3.
2
Synthesis and evaluation of Trehalose-Pks13 inhibitor conjugates targeting mycobacteria.靶向分枝杆菌的海藻糖-Pks13抑制剂缀合物的合成与评价
Carbohydr Res. 2025 Jul;553:109506. doi: 10.1016/j.carres.2025.109506. Epub 2025 May 3.
3
Genetic and Cheminformatic Characterization of Inhibitors Discovered in the Molecular Libraries Small Molecule Repository.分子文库小分子储存库中发现的抑制剂的遗传和化学信息学特征分析

本文引用的文献

1
SQ109 targets MmpL3, a membrane transporter of trehalose monomycolate involved in mycolic acid donation to the cell wall core of Mycobacterium tuberculosis.SQ109 靶向 MmpL3,一种海藻糖单胞壁酸的膜转运蛋白,参与分枝杆菌细胞壁核心的海藻糖单胞壁酸的供体。
Antimicrob Agents Chemother. 2012 Apr;56(4):1797-809. doi: 10.1128/AAC.05708-11. Epub 2012 Jan 17.
2
Elucidation and chemical modulation of sulfolipid-1 biosynthesis in Mycobacterium tuberculosis.阐明结核分枝杆菌中硫脂-1 生物合成及其化学调控。
J Biol Chem. 2012 Mar 9;287(11):7990-8000. doi: 10.1074/jbc.M111.315473. Epub 2011 Dec 22.
3
Novel 1,2,3-triazole derivatives for use against Mycobacterium tuberculosis H37Rv (ATCC 27294) strain.
ACS Infect Dis. 2025 Apr 11;11(4):882-893. doi: 10.1021/acsinfecdis.4c00936. Epub 2025 Mar 25.
4
Identification of a Series Containing a Pentafluorophenyl Moiety That Targets Pks13 to Inhibit Growth of .鉴定出一个含有五氟苯基部分的系列,该系列靶向Pks13以抑制……的生长。
ACS Infect Dis. 2025 Mar 14;11(3):715-726. doi: 10.1021/acsinfecdis.4c00808. Epub 2025 Feb 27.
5
Cryo-electron microscopy structure of the di-domain core of polyketide synthase 13, essential for mycobacterial mycolic acid synthesis.冷冻电镜结构的二域核心的聚酮化合物合酶 13,对分枝杆菌分枝菌酸的合成至关重要。
Microbiology (Reading). 2024 Oct;170(10). doi: 10.1099/mic.0.001505.
6
Polyketide Synthase 13 (Pks13) Inhibition: A Potential Target for New Class of Anti-tubercular Agents.聚酮合酶 13(Pks13)抑制:新型抗结核药物的潜在靶点。
Curr Top Med Chem. 2024;24(27):2362-2376. doi: 10.2174/0115680266322983240906055750.
7
Inhibitors of the Thioesterase Activity of Pks13 Discovered Using DNA-Encoded Chemical Library Screening.使用 DNA 编码化学库筛选发现 Pks13 的硫酯酶活性抑制剂。
ACS Infect Dis. 2024 May 10;10(5):1561-1575. doi: 10.1021/acsinfecdis.3c00592. Epub 2024 Apr 5.
8
Unlocking Opportunities for and .为 和 解锁机会。
ACS Infect Dis. 2024 Feb 9;10(2):251-269. doi: 10.1021/acsinfecdis.3c00371. Epub 2024 Jan 31.
9
Polyketide synthases mutation in tuberculosis transmission revealed by whole genomic sequence, China, 2011-2019.2011 - 2019年中国通过全基因组序列揭示的结核分枝杆菌传播中的聚酮合酶突变
Front Genet. 2024 Jan 8;14:1217255. doi: 10.3389/fgene.2023.1217255. eCollection 2023.
10
Repurposing an Antioxidant to Kill by Targeting the 50S Subunit of the Ribosome.通过靶向核糖体 50S 亚基来重新利用一种抗氧化剂来杀死 。
Biomolecules. 2023 Dec 14;13(12):1793. doi: 10.3390/biom13121793.
新型 1,2,3-三唑衍生物在抗结核分枝杆菌 H37Rv(ATCC 27294)株中的应用。
J Med Chem. 2011 Sep 8;54(17):5988-99. doi: 10.1021/jm2003624. Epub 2011 Aug 15.
4
Identifying vulnerable pathways in Mycobacterium tuberculosis by using a knockdown approach.利用敲低方法鉴定结核分枝杆菌中的脆弱途径。
Appl Environ Microbiol. 2011 Jul;77(14):5040-3. doi: 10.1128/AEM.02880-10. Epub 2011 Jun 3.
5
A Mycobacterium marinum TesA mutant defective for major cell wall-associated lipids is highly attenuated in Dictyostelium discoideum and zebrafish embryos.一株主要细胞壁相关脂类缺陷的海分枝杆菌 TesA 突变体在粘菌 Dictyostelium discoideum 和斑马鱼胚胎中高度减毒。
Mol Microbiol. 2011 May;80(4):919-34. doi: 10.1111/j.1365-2958.2011.07618.x. Epub 2011 Apr 6.
6
Depletion of antibiotic targets has widely varying effects on growth.抗生素靶标耗竭对生长的影响差异很大。
Proc Natl Acad Sci U S A. 2011 Mar 8;108(10):4176-81. doi: 10.1073/pnas.1018301108. Epub 2011 Feb 22.
7
Analysis of the Lipids of Mycobacterium tuberculosis.结核分枝杆菌脂质分析
Methods Mol Med. 2001;54:229-45. doi: 10.1385/1-59259-147-7:229.
8
β-Lactam and glycopeptide antibiotics: first and last line of defense?β-内酰胺类和糖肽类抗生素:第一道和最后一道防线?
Trends Biotechnol. 2010 Dec;28(12):596-604. doi: 10.1016/j.tibtech.2010.09.004. Epub 2010 Oct 21.
9
Best drug treatment for multidrug-resistant and extensively drug-resistant tuberculosis.耐多药和广泛耐药结核病的最佳药物治疗。
Lancet Infect Dis. 2010 Sep;10(9):621-9. doi: 10.1016/S1473-3099(10)70139-0.
10
How antibiotics kill bacteria: from targets to networks.抗生素如何杀死细菌:从靶点到网络。
Nat Rev Microbiol. 2010 Jun;8(6):423-35. doi: 10.1038/nrmicro2333. Epub 2010 May 4.